150 related articles for article (PubMed ID: 31503144)
1. Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis.
Wheeler LJ; Desanto K; Teal SB; Sheeder J; Guntupalli SR
Obstet Gynecol; 2019 Oct; 134(4):791-800. PubMed ID: 31503144
[TBL] [Abstract][Full Text] [Related]
2. Ever-use of the intra-uterine device and the risk of ovarian cancer.
Balayla J; Gil Y; Lasry A; Mitric C
J Obstet Gynaecol; 2021 Aug; 41(6):848-853. PubMed ID: 33045859
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
Cortessis VK; Barrett M; Brown Wade N; Enebish T; Perrigo JL; Tobin J; Zhong C; Zink J; Isiaka V; Muderspach LI; Natavio M; McKean-Cowdin R
Obstet Gynecol; 2017 Dec; 130(6):1226-1236. PubMed ID: 29112647
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine device use among women with ovarian cancer: a systematic review.
Zapata LB; Whiteman MK; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):38-40. PubMed ID: 20682141
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine device use and risk of ovarian cancer: Results from the New England Case-Control study and Nurses' Health Studies.
Yang J; Sasamoto N; Babic A; Vitonis AF; Townsend MK; Titus L; Cramer DW; Tworoger SS; Terry KL
Int J Cancer; 2021 Jul; 149(1):75-83. PubMed ID: 33634849
[TBL] [Abstract][Full Text] [Related]
6. Intrauterine device survival in Iranian women: systematic review and meta-analysis.
Farajzadegan Z; Motamedi N; Nouri R; Kheyri M
J Family Med Prim Care; 2015; 4(2):203-7. PubMed ID: 25949968
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.
Havrilesky LJ; Moorman PG; Lowery WJ; Gierisch JM; Coeytaux RR; Urrutia RP; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Obstet Gynecol; 2013 Jul; 122(1):139-147. PubMed ID: 23743450
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine Device Insertion Failure After Misoprostol Administration: A Systematic Review.
Matthews LR; OʼDwyer L; OʼNeill E
Obstet Gynecol; 2016 Nov; 128(5):1084-1091. PubMed ID: 27741184
[TBL] [Abstract][Full Text] [Related]
9. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
[TBL] [Abstract][Full Text] [Related]
10. Immediate postabortal insertion of intrauterine devices.
Grimes DA; Lopez LM; Schulz KF; Stanwood NL
Cochrane Database Syst Rev; 2010 Jun; (6):CD001777. PubMed ID: 20556754
[TBL] [Abstract][Full Text] [Related]
11. Is aspirin use associated with a decreased risk of ovarian cancer? A systematic review and meta-analysis of observational studies with dose-response analysis.
Zhang D; Bai B; Xi Y; Wang T; Zhao Y
Gynecol Oncol; 2016 Aug; 142(2):368-77. PubMed ID: 27151430
[TBL] [Abstract][Full Text] [Related]
12. The safety of intrauterine devices among young women: a systematic review.
Jatlaoui TC; Riley HEM; Curtis KM
Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
[TBL] [Abstract][Full Text] [Related]
13. Immediate postabortal insertion of intrauterine devices.
Grimes D; Schulz K; Stanwood N
Cochrane Database Syst Rev; 2002; (3):CD001777. PubMed ID: 12137634
[TBL] [Abstract][Full Text] [Related]
14. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of intrauterine device use and risk of endometrial cancer.
Beining RM; Dennis LK; Smith EM; Dokras A
Ann Epidemiol; 2008 Jun; 18(6):492-9. PubMed ID: 18261926
[TBL] [Abstract][Full Text] [Related]
16. An Integrative Review of Extended Use of Intrauterine Devices.
Harrison CV; Igwe-Kalu C; Eide L
Nurs Womens Health; 2023 Dec; 27(6):427-434. PubMed ID: 37863119
[TBL] [Abstract][Full Text] [Related]
17. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
Diedrich JT; Klein DA; Peipert JF
Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
[TBL] [Abstract][Full Text] [Related]
18. Uterine structural abnormality and intrauterine device malposition: analysis of ultrasonographic and demographic variables of 517 patients.
Gerkowicz SA; Fiorentino DG; Kovacs AP; Arheart KL; Verma U
Am J Obstet Gynecol; 2019 Feb; 220(2):183.e1-183.e8. PubMed ID: 30419198
[TBL] [Abstract][Full Text] [Related]
19. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
Mumford SD; Kessel E
Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
[TBL] [Abstract][Full Text] [Related]
20. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review.
Tepper NK; Steenland MW; Gaffield ME; Marchbanks PA; Curtis KM
Contraception; 2013 May; 87(5):655-60. PubMed ID: 23040135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
